Archived recommendations
This page shows our archived recommendations. These recommendations are no longer valid due to a number of factors i.e they have been superseded by NICE guidance or they are now out of date. Documents have been listed here in order of date that they were archived for information only.
| Title | Documents | Decision | Date | BNF Chapter | |
|---|---|---|---|---|---|
| Alfapump® device for the treatment of ascites due to Liver Cirrhosis | Recommendation | Device no longer available in UK | 07/06/2022 | 2 | |
| Solriamfetol for narcolepsy in adults | Recommendation | Superseded NICE TA available | 22/02/2022 | 4 | |
| Andexanet alfa (Ondexxya®) Factor Xa inhibitor antidote | Recommendation | Superseded NICE TA available | 08/06/2021 | 2 | |
| Brolucizumab for wAMD | Recommendation | Superseded NICE TA available | 23/02/2021 | 1 | |
| Erenumab and galcanezumab for prophylaxis of migraine | Recommendation | Superseded NICE TA available | 23/02/2021 | 4 | |
| Liraglutide (Saxenda®) for Obesity in adults | Recommendation | Superseded NICE TA available | 09/12/2021 | 1 | |
| Gastro-intestinal stimulation with the Enterra™ device for Gastroparesis (NETAG) | Recommendation | Superseded - NHSE Commissioning Statement available | 01/09/2020 | 1 | |
| Novel fentanyl products (Abstral®, Effentora® Instanyl® and PecFent®): Updated appraisal for breakthrough pain associated with cancer (NETAG) | Recommendation | Superseded by NHSE Items of Low Clinical Value Guidance | 12/07/2021 | 4 | |
| Bosentan (Tracleer®) for digital ulcers (NETAG) | Recommendation | Superseded - NHSE Commissioning Statement available | 20/04/2010 | 10 | |
| Tocilizumab (RoActemra®) for systemic-onset and polyarticular juvenile idiopathic arthritis (NETAG) | Recommendation | Superseded NICE TA available | 13/07/2010 | 10 | |
| Cervical spinal prosthetic disc replacement for degenerative cervical disc disease (NETAG) | Recommendation | Superseded - NHSE Commissioning Statement available | 20/03/2012 | 10 | |
| Patiromer cation exchange resin for hyperkalaemia | Recommendation | Superseded NICE TA available | 13/02/2020 | 9 | |
| Ozurdex® dexamethasone ocular implant for posterior segment uveitis (NETAG) | Recommendation Treatment protocol | Superseded NICE TA available | 26/07/2017 | 11 | |
| Eluxadoline (Truberzi®) for treatment of diarrhoea-dominant irritable bowel syndrome | Recommendation | Superseded NICE TA available | 06/09/2016 | 1 | |
| Alirocumab for hyperlipidaemia | Recommendation PCSK9 Pathway | Superseded NICE TA available | 24/11/2015 | 2 | |
| Evolocumab for hyperlipidaemia | Recommendation PCSK9 Pathway | Superseded NICE TA available | 24/11/2015 | 2 | |
| Biologic drugs for treatment-refractory moderate to severely active ulcerative colitis in younger patients (to avoid colectomy) | Recommendation | Superseded NICE TA available | 25/02/2015 | 1 | |
| Rivaroxaban for ACS | Recommendation | Superseded NICE TA available | 03/06/2014 | 2 | |
| Nalmefene in the management of alcohol dependence | Recommendation | Superseded NICE TA available | 25/02/2014 | 3 | |
| Certolizumab pegol (Cimzia®) for the treatment of Psoriatic Arthritis | Recommendation | Superseded NICE TA available | 08/09/2015 | 10 | |
| Collagenase (Xiapex®) for Dupuytren’s contracture (NETAG) | Recommendation | Superseded NICE TA available | 20/03/2012 | 10 | |
| Dimethyl fumarate for moderate to severe chronic plaque psoriasis | Recommendation | Superseded NICE TA available | 28/02/2017 | 13 |